SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001161697-21-000482
Filing Date
2021-10-12
Accepted
2021-10-12 08:27:30
Documents
14
Period of Report
2021-10-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT FOR 10-11-2021 form_8-k.htm   iXBRL 8-K 24212
2 PRESS RELEASE DATED OCTOBER 11, 2021 ex_99-1.htm EX-99 5279
3 GRAPHIC globestar_logo.jpg GRAPHIC 10744
  Complete submission text file 0001161697-21-000482.txt   231380

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE gstc-20211011.xsd EX-101.SCH 3028
5 XBRL LABEL FILE gstc-20211011_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE gstc-20211011_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT form_8-k_htm.xml XML 3462
Mailing Address 719 JADWIN AVENUE RICHLAND WA 99352
Business Address 719 JADWIN AVENUE RICHLAND WA 99352 206-451-1970
GlobeStar Therapeutics Corp (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: WY | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-55072 | Film No.: 211317037
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences